Skip to main content

Day: March 14, 2023

Paperclip Inc. Launches Electronic Signature Solution Focused on Security and Simplicity

eM4 Proof of Agreement offers e-sign alternative with improved functionality and ease of use over leading brands HACKENSACK, N.J., March 14, 2023 (GLOBE NEWSWIRE) — Paperclip, Inc. (OTCMKTS:PCPJ) has created an e-signature solution that is simpler and more secure than what most companies use today. Paperclip’s eM4 Proof of Agreement (POA) gives companies a better alternative to e-sign solutions that have become difficult to configure and manage. “People are recognizing more and more pain points with their e-signing solutions,” said Mike Bridges, President and COO of Paperclip Inc. “We knew there was a need for a simpler e-signing solution with easier setup for companies. eM4 POA makes e-signature and agreements simple, fast and secure—all at a lower cost than leading solutions.” The global e-signature market is growing rapidly...

Continue reading

Subsea7 completion of the acquisition of 187,889,551 shares in Seaway7

Luxembourg – 14 March 2023 – Subsea 7 S.A. (“Subsea7”) (Oslo Børs: SUBC, ADR: SUBCY) today announced that it has completed the acquisition of 187,889,551 shares in Seaway 7 ASA (“Seaway7”), corresponding to 21.52% of Seaway7’s issued and outstanding share capital, from Songa Capital AS, Lotus Marine AS and West Coast Invest AS. Following completion of the acquisition Subsea7 holds 93.94% of the issued and outstanding share capital of Seaway7. As consideration, Songa Capital AS, Lotus Marine AS and West Coast Invest AS have received 1 new Subsea7 share for every 22 Seaway7 shares, in total 8,540,433 new shares (the “Consideration Shares”) corresponding to approximately 2.90% of the current issued share capital of Subsea7. The Consideration Shares have the same rights as the existing Subsea7...

Continue reading

Seanergy Maritime Reports Financial Results for the Fourth Quarter and Twelve Months Ended December 31, 2022

Highlights   Quarterly   Full Year(in million USD except EPS)   Q4 2022 Q4 2021   FY 2022 FY 2021Net Revenues   $28.5 $56.7   $125.0 $153.1Net Income   $0.5 $20.6   $17.2 $41.3Adjusted Net Income1   $0.9 $27.9   $23.3 $53.3EBITDA1   $12.0 $31.5   $59.5 $78.9Adjusted EBITDA1   $12.5 $38.8   $65.6 $90.1             Earnings per Share (EPS) Basic1,2   $0.03 $1.21    $0.97 $2.70Earnings per Share (EPS) Diluted1,2   $0.03 $1.01   $0.96 $2.16 Adjusted EPS Basic1,2   $0.05 $1.63   $1.33 $3.48 Adjusted EPS Diluted1,2   $0.05 $1.36   $1.32 $2.78 Other Highlights and Developments:Quarterly cash dividend of $0.025 per share for Q4 2022 – resulting in total cash dividends of $1.275 per share or $22.9 million declared since April 2022. Spin-off of United Maritime Corporation (NASDAQ: USEA) to our shareholders...

Continue reading

AB INTL GROUP Announces NFT MMM License Business Updates

NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) — AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm today announced NFT Movie and Music Marketplace License business updates. AB granted to the operator a worldwide license to a NFT movie music marketplace (the “NFT MMM”), AB consistently generated revenue from license fee monthly since August 2022. On March 13, 2023, AB signed an agreement with a digital crypto assets management operator. AB granted to the management company a worldwide license to a NFT movie music marketplace (the “NFT MMM”). AB will be additional income from the issuer annual fee beside fix monthly license fee. Under the agreement AB will generate $1.1 million to $2 million annual revenue, AB is developing enhance function version. AB plans continue partnership...

Continue reading

Aware Announces New Partnership with Uqoud to Bring Biometrics to Contract Management Platform

Uqoud Has Integrated Knomi®, Aware’s Industry-Leading Mobile Biometric Authentication Framework, Into its Contract Management Platform BURLINGTON, Mass., March 14, 2023 (GLOBE NEWSWIRE) — Aware, Inc. (NASDAQ: AWRE) today announced a new partnership with Middle East-based contract management platform provider Uqoud to integrate Knomi®, Aware’s industry-leading mobile biometric authentication framework, into the Uqoud platform. As a new part of Uqoud’s contract management platform, Knomi will enable Uqoud to onboard new users remotely using facial biometrics and identity verification and also continuously authenticate users through facial biometrics. This integration will empower Uqoud users to securely verify the identity of all stakeholders involved in contract signings with minimal friction. “Aware’s partnership with Uqoud represents...

Continue reading

Aridis Pharmaceuticals Announces $2.28 Million Registered Direct Offering of Common Stock

Los Gatos, Calif., March 14, 2023 (GLOBE NEWSWIRE) — Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company, today announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 6,000,000 shares of the Company’s common stock at a purchase price of $0.38 per share in a registered direct offering. The closing of the offering is expected to occur on or about March 16, 2023, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds to the Company from the offering are expected to be $2.28 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. Aridis Pharmaceuticals currently intends to use the net proceeds from the offering...

Continue reading

Calavo Growers Declares Quarterly Dividend

SANTA PAULA, Calif., March 14, 2023 (GLOBE NEWSWIRE) — Calavo Growers, Inc. (Nasdaq: CVGW), a global avocado-industry leader and provider of convenient, ready-to-eat fresh food, today announced that its board of directors declared a quarterly cash dividend on its common stock of $0.10 per share. The dividend will be paid on April 6, 2023, to Calavo Grower’s shareholders of record as of the close of business on March 24, 2023. About Calavo Growers, Inc.Calavo Growers, Inc. (Nasdaq: CVGW) is a global leader in quality produce, including avocados, tomatoes and papayas, and a pioneer of healthy fresh-cut fruit, vegetables and prepared foods. Calavo products are sold under the trusted Calavo brand name, proprietary sub-brands, private label and store brands. Founded in 1924, Calavo has a rich culture of constant innovation, sustainable...

Continue reading

Elcora Options to Purchase Existing Manganese Mine In Morocco

HALIFAX, Nova Scotia, March 14, 2023 (GLOBE NEWSWIRE) — ELCORA ADVANCED MATERIALS CORP. (TSX.V:ERA | Frankfurt:ELM | OTCQB – ECORF), (the “Company” or “Elcora”), is pleased to announce that it has signed, through its Ermazon SARL wholly owned subsidiary, a binding agreement with exclusive long term mining production rights and option to purchase the 16 km² Manganese mining concession (“Deposit”) in Morocco. This Manganese Deposit had been mined until a few years ago when COVID crisis strict rules prevented further development. The artisanal production run rate at the Deposit was then approximately 2,500 metric tonnes / month, our local team believes there is potential for more by adding appropriate equipment. Combined with Elcora’s own Manganese ore Atlas Fox Deposit, it brings the Company’s...

Continue reading

VBL Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update

MODIIN, Israel and NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT) (VBL), today announced financial results for the fiscal year ended December 31, 2022, and provided a corporate update. “I am confident that the recently announced merger with Notable Labs Inc. provides the best path forward and will position the new enterprise to deliver both near and long-term value for shareholders of both companies and patients,” said Prof. Dror Harats, M.D., Chief Executive Officer of VBL Therapeutics. “The successful closing of the sale of VBL’s manufacturing facility for $7.1 million has provided an influx of non-dilutive capital that can be employed by the combined entity to advance its pipeline. I am impressed by the management team at Notable, who have an excellent track record developing successful pharmaceuticals,...

Continue reading

MeiraGTx Reports Fourth Quarter and Full Year 2022 Financial and Operational Results

–   Announced positive clinical data from AQUAx AAV-hAQP1 Phase 1 trial for treatment of Grade 2/3 Radiation-Induced Xerostomia in December 2022 –   Announced positive top-line data from the MGT009 Phase 1/2 clinical study demonstrating safety and improvement in multiple domains of vision in X-linked retinitis pigmentosa (XLRP) patients treated with botaretigene sparoparvovec (AAV-RPGR) compared to untreated randomized control at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting –   Continued enrollment and dosing of patients in pivotal Phase 3 Lumeos clinical trial of botaretigene sparoparvovec for the treatment of XLRP –   On track for BLA submission of botaretigene sparoparvovec for the treatment of XLRP in 2024 LONDON and NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (Nasdaq:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.